Aurora, a Leading Global Medical Cannabis Company, Attends the H.C. Wainwright 27th Annual Global Investment Conference

Date:

NASDAQ| TSX: ACB

EDMONTON, AB, Sept. 8, 2025 /CNW/ – Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, will be attending the H.C. Wainwright 27th Annual Global Investment Conference in New York City, NY. Simona King, Chief Financial Officer at Aurora, will conduct one-on-one meetings with investors throughout the conference on September 8-10, 2025.

Simona has prepared a presentation highlighting Aurora’s strategic investments and how the company plans to continue delivering long-term shareholder value in the evolving medical cannabis industry.

To listen to this presentation, please follow the weblink HERE, which has also been posted to the Company’s “Investor Info” section at https://www.auroramj.com/investors/ under “Events”. A replay of the presentation will be available using the same link for…

Read more…

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Tampa RV giant Lazydays to delist from Nasdaq

Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...

Granite Geek: New Hampshire might get access to ‘balcony solar’

I had solar panels put on my roof six...

TSX Today: What to Watch for in Stocks on Monday, November 10

Despite firm gold and silver prices, Canadian stocks...

While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!

As market-wide fear grips the sector, the Binance Coin...